Aratana Therapeutics

^{Priced, Nasdaq: PETX}

Developing medications for cats and dogs based on therapies for humans.

Industry: Health Care

First Day Return: +37.7%

PETX

Developing medications for cats and dogs based on therapies for humans.

IPO News for Aratana Therapeutics

Paining cats and dogs: Nexvet sets terms for $58 million IPO 01/26/15
US IPO Recap: Market picks up the pace with ten IPOs, six price below the range 07/01/13
All five IPOs price below original range on Wednesday, most in one day since June 1998 06/27/13

IPO Data
IPO Date	06/26/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$35
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.aratana.com
Headquarters	Kansas City, KS, United States
Founded	2010
Employees at IPO	16

IPO News for Aratana Therapeutics

Aratana Therapeutics (PETX) Performance